Absci Corporation
ABSI
$3.35
-$0.04-1.18%
Rating Factors
Growth Index
Efficiency Index
--
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
1/10/2023
-
BizJournals.com - Nat'l Business News
1/10/2023
-
Insider Monkey
1/10/2023
-
Bizjournals.com - Health Care News
1/10/2023
-
Globe Newswire
1/10/2023
-
GeekWire
1/8/2023
-
Globe Newswire
1/3/2023
-
ETF Channel
12/28/2022
-
Globe Newswire
12/27/2022
-
GeekWire
12/19/2022
-
Ticker Report
12/14/2022
-
Benzinga
12/1/2022
-
ETF Channel
11/30/2022
-
GeekWire
11/23/2022
-
Globe Newswire
11/17/2022
-
Globe Newswire
11/14/2022
-
Zolmax
11/12/2022
-
Ticker Report
11/11/2022
-
Simply Wall St
11/9/2022
-
Bizjournals.com - Health Care News
11/9/2022
-
BizJournals.com - Nat'l Business News
11/9/2022
-
Zacks Investment Research
11/9/2022
-
Globe Newswire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, November 9, 2022
Period Date
Friday, September 30, 2022
Next Filing
Week of Mar 20 and 24 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
360 949 1041
Address
18105 SE Mill Plain Boulevard
Vancouver, WA 98683
Vancouver, WA 98683
Country
Year Founded
Business Description
Sector
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its...
more
